INDGN2025-04-012025-06-30INDGN2025-04-012025-06-30in-capmkt:OtherExpenses1MemberINDGN2025-04-012025-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1INDGN2025-04-012025-06-30AuditorDomain1iso4217:INRiso4217:INRxbrli:shares544172INDGNNOTLISTEDINE065X01017Indegene LimitedMain BoardEquity2025-04-012026-03-312025-07-312025-07-24INRMillionsQuarterlyFirst quarterSingle segmentWhere financial results contain both consolidated financial results and standalone financial results of the parent, segment information is required to be presented only in the consolidated financial results. Accordingly, segment information has been presented in the consolidated financial results.2025-07-3116:40:002025-07-3116:58:00Declaration of unmodified opinionfalsefalseNo external loans and debt securities held by Company2025-04-012025-06-30UnauditedStandalone255600000032100000028770000000001816000000170000007300000037300000022790000005980000000598000000145000000200000014700000004510000000000451000000900000046000000047900000021.881.87001.881.87Earnings per share is not annualised for quarter ended <BR> <BR> Notes to the Statement of Standalone Financial Results for quarter ended 30 June 2025 All amounts in INR millions except share data and where otherwise stated <BR> 1 The above Standalone Financial Results of the Indegene Limited the Company have been prepared in accordance with Indian Accounting Standards Ind AS 34 Interim Financial Reporting recognition and measurement principles of Indian Accounting Standards Ind AS prescribed under Section 133 of the Companies Act 2013 as amended read with the relevant rules issued there under and in terms of Regulation 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 the Regulations Due to rounding off the numbers presented throughout may not add up precisely to the totals The symbol caret in the financial information denote amounts less than INR 5 lakhs <BR> 2 The above Standalone Financial Results have been reviewed by the Audit Committee meeting held on 29 July 2025 and approved by the Board of Directors at its meeting held on 31 July 2025 The statutory auditors have performed a limited review of the Standalone Financial Results for the quarter ended 30 June 2025 and have issued an unmodified review report on the same <BR> 3 The Standalone Financial Results include the results for the quarter ended 31 March 2025 being the balancing figures between audited figures in respect of full financial year up to 31 March 2025 and the unaudited published year to date figures up to 31 December 2024 being the date of the end of the third quarter of the financial year which were subjected to a limited review <BR> 4 The Standalone Financial Results for the quarter ended 30 June 2025 are available on the National Stock Exchange of India Limited URL www nseindia com the BSE Limited website URL www bseindia com and on the Company s website URL www indegene com investor relations <BR> 5 The Company publishes this Standalone Financial Results along with the Consolidated Financial Results In accordance with Ind AS 108 Operating Segments the Company has disclosed the segment information in the Consolidated Financial Results <BR> 6 Final dividend for the financial year 2024 25 of INR 2 per share was approved by the shareholders at the 27th Annual General Meeting held on 26 June 2025 and the same was paid on 30 June 2025Other expenses373000000Remeasurement of defined benefit obligation1200000012000000300000009000000UnauditedtrueDeloitte Haskins & Sellstrue2028-04-30